Protagonist Therapeutics (PTGX) Receivables - Other (2017 - 2026)
Protagonist Therapeutics (PTGX) posted Receivables - Other of $3.5 million for Q1 2026, down 20.76% sequentially from $4.4 million in Q4 2025, and down 84.85% YoY from $22.8 million in Q1 2025.
Protagonist Therapeutics (PTGX) Receivables - Other (2017 - 2026) Analysis & Trends
Protagonist Therapeutics has reported Receivables - Other for 10 years, with the latest figure at $3.5 million in Q1 2026.
- Quarterly Receivables - Other fell 84.85% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (down 84.85% YoY) and the FY2025 annual result came in at $4.4 million, up 34.64% from the prior year.
- Receivables - Other fell to $3.5 million in Q1 2026 per PTGX's latest filing, from $4.4 million in the prior quarter.
- Over five years, Receivables - Other peaked at $23.4 million in Q2 2025 and troughed at $39000.0 in Q2 2023.
- A 5-year average of $4.9 million and a median of $672000.0 in 2022 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2022 and 2024: Receivables - Other plunged 97.32% in 2022, then jumped 1166.41% in 2024.
- Over 5 years, Receivables - Other stood at $42000.0 in 2022, then jumped by 509.52% to $256000.0 in 2023, then surged by 1166.41% to $3.2 million in 2024, then soared by 34.64% to $4.4 million in 2025, then slipped by 20.76% to $3.5 million in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $3.5 million, $4.4 million, and $4.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Protagonist Therapeutics | 10.03 Bn | 10.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.37 Mn |
| Jun 30, 2026 | 3.37 Mn |
| Mar 31, 2026 | 3.46 Mn |
| Mar 31, 2026 | 3.46 Mn |
| Dec 31, 2025 | 4.37 Mn |
| Dec 31, 2025 | 4.37 Mn |
| Sep 30, 2025 | 4.55 Mn |
| Sep 30, 2025 | 4.55 Mn |
| Jun 30, 2025 | 23.36 Mn |
| Jun 30, 2025 | 23.36 Mn |
| Mar 31, 2025 | 22.83 Mn |
| Mar 31, 2025 | 22.83 Mn |
| Dec 31, 2024 | 3.24 Mn |
| Dec 31, 2024 | 3.24 Mn |
| Dec 31, 2023 | 256,000.00 |
| Dec 31, 2023 | 256,000.00 |
| Jun 30, 2023 | 39,000.00 |
| Jun 30, 2023 | 39,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Mar 31, 2023 | 51,000.00 |